Fresenius SE & Co. KGaA (FRE) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 55 PAGES: 52

Fresenius SE & Co. KGaA (FRE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fresenius SE & Co. KGaA (Fresenius) is a global health care group, which offers products and

More Info
									                 Fresenius SE & Co. KGaA (FRE) - Financial and Strategic SWOT
                                      Analysis Review
        Reference Code: GDME698FSA                                                                                             Publication Date: JUN 2013

          Else-Kroener-Str. 1                                Phone               +49 6172 6080                  Revenue          19,508 (million EUR)
          Bad Homburg                                        Fax                 +49 617 26082294               Net Profit       930 (million EUR)
          61352                                              Website             www.fresenius.com              Employees        171,764
          Germany                                            Exchange            FRE [XETRA]                    Industry         Medical Equipment

       Company Overview
       Fresenius SE & Co. KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It
       provides various dialysis services through its own clinics, as well as sells its products to other dialysis service providers. The
       company’s offerings include clinical laboratory testing, therapeutic aphaeresis, hemoperfusion, and inpatient dialysis services
       among others. Fresenius conducts operations in Asia-Pacific, Europe, North America, Latin America and South Africa with major
       plants in the US, Germany, China, Sweden and Japan. The company is headquartered in Bad Homburg, Germany.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Fresenius SE & Co. KGaA, SWOT Analysis
         Ben Lipps                           Chairman,             Fresenius          Strengths                              Weaknesses
                                             Medical Care
                                                                                      Decentralized Organization             Product Recalls
         Ulf M. Schneider                    Chairman
                                                                                      Structure
         Rainer Baule                        Chief Executive          Officer,                                               Erythropoietin Supplies
                                             Fresenius Kabi                           Operational Diversity
         Jurgen Gotz                         Chief Compliance Officer
         Stephan Sturm                       Chief Financial Officer                  Opportunities                          Threats
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Expansion in High Growth               Integration of Acquisitions
                                                                                      Markets
       Share Data                                                                                                            Risk of Infection
                                                                                      Regulatory Support
         Fresenius SE & Co. KGaA
        Share Price (EUR) as on 07-Jun-                                91.72
        2013                                                                         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        EPS (EUR)                                                        5.32
        Market Cap (million EUR)                                      16,362
        Enterprise Value (million EUR)                                32,083
        Shares Outstanding (million)                                     178
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Feb 26, 2013         Fresenius Reports Revenue Of €19.3 Billion In
                                                                                                           2012
                                                                                      Dec 14, 2012         Fresenius Announces Decision To Discontinue
                                                                                                           Biotechnology Business
                                                                                      Oct 31, 2012         Fresenius Reports Revenue Of €4.9 Billion In
                                                                                                           Q3 2012
                                                                                      Aug 01, 2012         Fresenius Reports Revenue Of €4.8 Billion In
                                                                                                           Q2 2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Fresenius SE & Co. KGaA (FRE) - Financial and Strategic SWOT                                                                      Reference Code: GDME698FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Fresenius SE & Co. KGaA - Key Facts .............................................................................................................................................. 5
       Fresenius SE & Co. KGaA - Key Employees ..................................................................................................................................... 6
       Fresenius SE & Co. KGaA - Key Employee Biographies ................................................................................................................... 7
       Fresenius SE & Co. KGaA - Major Products and Services................................................................................................................. 8
       Fresenius SE & Co. KGaA - Pharmaceutical Pipeline Products Data .............................................................................................. 10
          Fresenius SE & Co. KGaA, Pipeline Products by Therapy Area................................................................................................... 10
          Fresenius SE & Co. KGaA, Pipeline Products by Development Phase ........................................................................................ 11
       Fresenius SE & Co. KGaA - History ................................................................................................................................................. 12
       Fresenius SE & Co. KGaA - Company Statement............................................................................................................................ 15
       Fresenius SE & Co. KGaA - Locations And Subsidiaries ................................................................................................................. 17
          Head Office ................................................................................................................................................................................... 17
          Other Locations & Subsidiaries ..................................................................................................................................................... 17
       Fresenius SE & Co. KGaA - Key Manufacturing Facilities................................................................................................................ 20
          Joint Venture................................................................................................................................................................................. 21
          BusinessUnit ................................................................................................................................................................................. 21
       Section 2 – Company Analysis ......................................................................................................................................................... 22
       Fresenius SE & Co. KGaA - Business Description ........................................................................................................................... 22
          Business Description - Fresenius Helios....................................................................................................................................... 22
             Fresenius Helios - Overview ..................................................................................................................................................... 22
             Fresenius Helios - Financials .................................................................................................................................................... 22
             Fresenius Helios - Capital Expenditure ..................................................................................................................................... 22
          Business Description - Fresenius Kabi ......................................................................................................................................... 22
             Fresenius Kabi - Overview ........................................................................................................................................................ 22
             Fresenius Kabi - Financials ....................................................................................................................................................... 23
             Fresenius Kabi - Capital Expenditure ........................................................................................................................................ 23
             Fresenius Kabi - Market View ................................................................................................................................................... 23
          Business Description - Fresenius Medical Care ........................................................................................................................... 23
             Fresenius Medical Care - Overview .......................................................................................................................................... 23
             Fresenius Medical Care - Financials ......................................................................................................................................... 23
             Fresenius Medical Care - Capital Expenditure .......................................................................................................................... 23
             Fresenius Medical Care - Market View...................................................................................................................................... 23
             Fresenius Medical Care - Technology ....................................................................................................................................... 24
          Business Description - Fresenius Vamed ..................................................................................................................................... 24
             Fresenius Vamed - Overview .................................................................................................................................................... 24
             Fresenius Vamed - Financials ................................................................................................................................................... 24
             Fresenius Vamed - Capital Expenditure .................................................................................................................................... 24
       Fresenius SE & Co. KGaA - Corporate Strategy .............................................................................................................................. 25
       Fresenius SE & Co. KGaA - SWOT Analysis ................................................................................................................................... 26
          SWOT Analysis - Overview........................................................................................................................................................... 26
          Fresenius SE & Co. KGaA - Strengths ......................................................................................................................................... 26
             Strength - Decentralized Organization Structure ....................................................................................................................... 26


Fresenius SE & Co. KGaA (FRE) - Financial and Strategic SWOT                                                                                                      Reference Code: GDME698FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
             Strength - Operational Diversity ................................................................................................................................................ 26
             Strength - Focused Research and Development Activities ....................................................................................................... 26
             Strength - Constant Growth in Revenues .................................................................................................................................. 27
          Fresenius SE & Co. KGaA - Weaknesses .................................................................................................................................... 27
             Weakness - Product Recalls ..................................................................................................................................................... 27
             Weakness - Erythropoietin Supplies........................................................................................
								
To top